Inventor · disambiguated record
Alan T. Remaley
Also filed as: REMALEY ALAN · REMALEY ALAN T · REMALEY ALAN THOMAS
18 granted patents·16 pending applications·156 citations·filing 1998–2023
92Inventor score
Files withUS HEALTH11REMALEY ALAN T5THE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES3LIPOSCIENCE INC2UNIV NORTH TEXAS2
Top patents by PatentIndex Score
34 records- 0190US10925938B2Composition comprising PCSK9 peptide conjugated to a Qbeta carrier and methods of using the sameTHE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES·Filed 2019·Granted Feb 23, 2021·3 cites·14 claims
- 0284US10279019B2PCSK9 peptide vaccine conjugated to a Qbeta carrier and methods of using the sameUS HEALTH·Filed 2015·Granted May 7, 2019·2 cites·16 claims
- 0382US11827690B2ApoC-II mimetic peptidesUS HEALTH·Filed 2021·Granted Nov 28, 2023·1 cites·6 claims
- 0481US11136372B2ApoC-II mimetic peptidesTHE US SECRETARY DEPT OF HEALTH & HUMAN SERVICES·Filed 2018·Granted Oct 5, 2021·3 cites·30 claims
- 0581US7572771B1Multi-domain amphipathic helical peptides and methods of their useUS HEALTH·Filed 2005·Granted Aug 11, 2009·5 cites·21 claims
- 0678US11872261B2Lipoprotein targeting protease inhibitors and usesUS HEALTH·Filed 2022·Granted Jan 16, 2024·0 cites·8 claims
- 0777US6556951B1System and method for intelligent quality control of a processUS HEALTH·Filed 1998·Granted Apr 29, 2003·104 cites·33 claims
- 0876US2023201298A1Lipoprotein targeting protease inhibitors and usesUS HEALTH·Filed 2022·Application pending·0 cites
- 0975US8148323B2Method of treating or inhibiting inflammation by multi-domain amphipathic helical peptidesREMALEY ALAN T·Filed 2010·Granted Apr 3, 2012·3 cites·8 claims
- 1073US8835378B2Multi-domain amphipathic helical peptides and methods of their useREMALEY ALAN T·Filed 2012·Granted Sep 16, 2014·2 cites·29 claims
- 1173US8071746B2Isolated nucleic acid molecule encoding a peptide or peptide analog comprising the SEQ ID No. 3REMALEY ALAN T·Filed 2009·Granted Dec 6, 2011·2 cites·5 claims
- 1273US2020078434A1Lipoprotein targeting protease inhibitors and usesUS HEALTH·Filed 2019·Application pending·0 cites
- 1372US8936787B2Peptides promoting lipid effluxREMALEY ALAN T·Filed 2009·Granted Jan 20, 2015·2 cites·20 claims
- 1470US11696941B2Compositions comprising a PCSK9 peptide conjugated to a qbeta carrier and methods of using the sameTHE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES·Filed 2021·Granted Jul 11, 2023·0 cites·14 claims
- 1568US6846636B1Methods and compositions for HDL holoparticle uptake receptorAMERICAN NAT RED CROSS·Filed 1999·Granted Jan 25, 2005·27 cites·3 claims
- 1667US2023024795A1Methods and Systems to Detect and Quantify the Amount of LP-X and Other Abnormal Lipoproteins in a Biosample Using NMR SpectroscopyLIPOSCIENCE INC·Filed 2022·Application pending·0 cites
- 1763US2017319643A1Lipoprotein targeting protease inhibitors and usesUS HEALTH·Filed 2016·Application pending·0 cites
- 1861US11467171B2Methods and systems to detect and quantify the amount of LP-X and other abnormal lipoproteins in a biosample using NMR spectroscopyLIPOSCIENCE INC·Filed 2018·Granted Oct 11, 2022·0 cites·20 claims
- 1961US9314532B2Drug delivery vehicleUNIV NORTH TEXAS·Filed 2013·Granted Apr 19, 2016·0 cites·31 claims
- 2060US11633471B2Compositions and methods for reducing serum triglyceridesUNM RAINFOREST INNOVATIONS·Filed 2019·Granted Apr 25, 2023·0 cites·14 claims
- 2160US2025304622A1Short apolipoprotein e mimetic peptides and methods of useUS HEALTH·Filed 2023·Application pending·0 cites
- 2259US2025235421A1Very-long-chain polyunsaturated fatty acids (vlcpufa) for improving retina/cognitive functions and atherosclerosisNISSUI CORP·Filed 2023·Application pending·0 cites
- 2354US2024309065A1Short apoc-ii mimetic peptides and methods of useUS HEALTH·Filed 2022·Application pending·0 cites
- 2453US2015343069A1Drug delivery vehicleUNIV NORTH TEXAS·Filed 2015·Application pending·0 cites
- 2552US2024010601A1Methods to produce very long chain fatty acids (vlcfa)THE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN·Filed 2021·Application pending·0 cites
- 2652US2017333563A1Drug delivery vehicleUNIV OF NORTH TEXAS HEALTH SCIENCE CENTER·Filed 2017·Application pending·0 cites
- 2752US2009011974A1Scavenger Receptor B1 (Cla-1) Targeting for the Treatment of Infection, Sepsis and InflammationBOCHAROV ALEXANDER V·Filed 2003·Application pending·0 cites
- 2849US2022178953A1Methods for assessing cardiovascular disease or inflammatory disease risk using non-exchangeable lipid probeUS HEALTH·Filed 2020·Application pending·0 cites
- 2944US2023017266A1Cyclooxygenase-2 Inhibition for the Treatment of SAA-high AsthmaTHE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES·Filed 2020·Application pending·0 cites
- 3042US2014213502A1Chemical modification of apolipoprotein mimetic peptides for the production of therapeutic agentsREMALEY ALAN T·Filed 2012·Application pending·0 cites
- 3140US7378274B2Regulatory nucleic acid for the ABC1 gene, molecules modifying its activity and therapeutic usesAVENTIS PHARMA SA·Filed 2001·Granted May 27, 2008·0 cites·11 claims
- 3240US2011034419A1Cardioprotective Drugs and Diagnostics for Assessing Risk of Cardiovascular DiseaseMUSC FOUND FOR RES DEV·Filed 2010·Application pending·0 cites
- 3337US2016074473A1Effect of phospholipid composition of reconstituted hdl on its cholesterol efflux and anti-inflammatory propertiesKINEMED INC·Filed 2015·Application pending·0 cites
- 3423US6154706AApparatus and method for kinetic analysis of the intraoperative assay for parathyroid hormoneFiled 1999·Granted Nov 28, 2000·2 cites·78 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →